Pharmacolog i Uppsala AB (publ) has appointed Sofia Uhrbom as interim Chief Financial Officer (CFO). Sofia will assume her role at Pharmacolog on June 1, 2023, and be part of the management team.
Sofia has a high school diploma in finance and solid experience as CFO from several owner-managed companies in Sweden with an international group structure. Most recently, Sofia worked at Svensk Galopp where she was administrative manager.
Lars Gusch, CEO of Pharmacolog comments: “I wish Liselotte Söder, who on her own initiative has chosen to leave the role as interim CFO, good luck with her new assignments and thank her for the valuable work done at Pharmacolog. At the same time, I am pleased to welcome Sofia to Pharmacolog and the role as interim CFO. With extensive experience from financial reporting, accounting and financial control in an international environment, she will be a key player for us in our growth journey.”
For more information contact:
Lars Gusch, CEO
Phone: +46 70-223 97 72
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.
Further information regarding the company is available at https://pharmacolog.com/.
The company’s Certified Adviser is Mangold Fondkommission AB.